Expression of polypeptide N-acetylgalactosaminyltransferase-10 in lung cancer#br#

CAI Cui-Xia; GAO Yuan; LIU Yue; WANG Han-Duo

doi:10.16098/j.issn.0529-1356.2020.02.009

PDF(8986 KB)

Acta Anatomica Sinica ›› 2020, Vol. 51 ›› Issue (2) : 206-210. DOI: 10.16098/j.issn.0529-1356.2020.02.009

Cancer Biology

Expression of polypeptide N-acetylgalactosaminyltransferase-10 in lung cancer#br#

CAI Cui-xia GAO Yuan LIU Yue WANG Han-duo*

Author information +

History +

Abstract

Objective The purpose of this study is to investigate the expression of the polypeptide N-acetylgalactosaminyltransferase-10(ppGalNAc-T10) protein in lung and breast and colon cancer. Methods Immunohistochemistry was used to analyse ppGalNAc-T10 expressions in 110 lung cancer tissues, 100 breast cancer tissues and 110 colon cancer tissues. Meanwhile, different cancer has 10 cases of normal tissues as control. Results The expression of ppGalNAc-T10 in normal lung tissue was higher compared with that in lung cancer organizations, and ppGalNAc-T10 positive expression was found to be significantly associated with invasion depth of tumor (P<0.01). PpGalNAc-T10 protein expression in breast and colon cancer was no significantly difference than that in non-tumor breast and colon tissue. Conclusion PpGalNAc-T10 expression is a useful marker in lung cancer.

Key words

Lung cancer / / Breast cancer / / Colon cancer / / Polypeptide N-acetylgalactosaminyltransferase-10 / Human

Cite this article

EndNote

Ris (Procite)

Bibtex

Download Citations

CAI Cui-xia GAO Yuan LIU Yue WANG Han-duo. Expression of polypeptide N-acetylgalactosaminyltransferase-10 in lung cancer#br#[J]. Acta Anatomica Sinica. 2020, 51(2): 206-210 https://doi.org/10.16098/j.issn.0529-1356.2020.02.009

References

［1］ Ten Hagen KG, Fritz TA, Tabak LA, et al. All in the family: the UDP-GalNAc:polypeptide N-acetylgalactosaminyltransferases［J］. Glycobiologyvol, 2003, 13(1): 1R-16R.

［2］ Huang MJ, Hu RH, Chou CH, et al. Knockdown of GALNT1 suppresses malignant phenotype of hepatocellular carcinoma by suppressing EGFR signaling［J］. Oncotarget, 2015, 6(8):5650-5665.

［3］ Guo JM, Chen HL, Wang GM, et al. Expression of UDP-GalNAc:polypeptide N-acetylgalactosaminyltransferase-12 in gastric and colonic cancer cell lines and in human colorectal cancer［J］. Oncology, 2004, 67(34):271-276.

［4］ Gu C, Oyama T, Osaki T, et al. Low expression of polypeptide GalNAc N-acetylgalactosaminyl transferase-3 in lung adenocarcinoma: impact on poor prognosis and early recurrence［J］. Br J Cancer, 2004, 90(2):436-442.

［5］ Wang ZQ, Bachvarova M, Morin C, et al. Role of the polypeptide N-acetylgalactosaminyltransferase 3 in ovarian cancer progression: possible implications in abnormal mucin O-glycosylation［J］. Oncotarget, 2014, 5(2):544-560.

［6］ Lina MC, Huang MJ, Liu CH, et al. GALNT2 enhances migration and invasion of oral squamous cell carcinoma by regulating EGFR glycosylation and activity［J］. Oral Oncology, 2014, 50(5):478-484.

［7］ Gao Y, Liu Z, Feng J, et al. Expression pattern of polypeptide N-acetylgalactosaminyltransferase-10 in gastric carcinoma［J］. Oncol Lett, 2013, 5(1):113-116.

［8］ Li Z, Yamada S, Wu Y, et al. Polypeptide N-acetylgalactosaminyltransferase-6 expression independently predicts poor overall survival in patients with lung adenocarcinoma after curative resection［J］. Oncotarget, 2016, 7(34): 54463-54473

［9］ Berois N, Mazal D, Ubillos L, et al. UDP-N-Acetyl-D-Galactosamine: Polypeptide N-Acetylgalactosaminyltransferase-6 as a New Immunohistochemical Breast Cancer Marker［J］. J Histochem Cytochem, 2006, 54(3): 317-328.

［10］ He H, Shen Z, Zhang H, et al. Clinical significance of polypeptide N-acetylgalactosaminyl transferase-5 (GalNAc-T5) expression in patients with gastric cancer［J］. Br J Cancer, 2014, 110(8): 2021-2029.